LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy

Cell Death and Disease

Volumn 8, Issue 2, 2017, Pages

  Yi, Hong ^a   Peng, Rui ^a   Zhang, Lu Yu ^a   Sun, Yan ^a   Peng, Hui Min ^a   Liu, Han Deng ^a   Yu, Li Juan ^a   Li, Ai Ling ^a   Zhang, Ya Juan ^a   Jiang, Wen Hao ^a   Zhang, Zheng ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; LONG UNTRANSLATED RNA; PROTEIN P50; BIOLOGICAL MARKER; CYTOKINE; NLRP3 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DB/DB MOUSE; DIABETIC NEPHROPATHY; GENE OVEREXPRESSION; HUMAN; INFLAMMATION; KIDNEY FIBROSIS; KIDNEY TISSUE; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; QUANTITATIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; EXPERIMENTAL DIABETES MELLITUS; FIBROSIS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BIOMARKERS; CELL LINE; CELL PROLIFERATION; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; FIBROSIS; INFLAMMASOMES; INFLAMMATION; MESANGIAL CELLS; MICE; NF-KAPPA B; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; RNA, LONG NONCODING; SIGNAL TRANSDUCTION;

EID: 85011578559     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2016.451     Document Type: Article

References (72)

1. Himmelfarb J, Tuttle KR. New therapies for diabetic kidney disease. N Engl J Med 2013; 369: 2549-2550.
2. Elmarakby AA, Sullivan JC. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc Ther 2012; 30: 49-59.
3. Sun Y, Peng R, Peng H, Liu H, Wen L, Wu T , et al. miR-451 suppresses the NF-kappaBmediated proinflammatory molecules expression through inhibiting LMP7 in diabetic nephropathy. Mol Cell Endocrinol 2016; 433: 75-86.
4. Yang X, Wang Y, Gao G. High glucose induces rat mesangial cells proliferation and MCP-1 expression via ROS-mediated activation of NF-B pathway, which is inhibited by eleutheroside E. J Recept Signal Transduct Res 2016; 36: 152-157.
5. Sun L, Kanwar YS. Relevance of TNF-in the context of other inflammatorycytokines in the progression of diabetic nephropathy. Kidney Int 2015; 88: 662-665.
6. Xu L, Shen P, Bi Y, Chen J, Xiao Z, Zhang X , et al. Danshen injection ameliorates STZ-induced diabetic nephropathy in association with suppression of oxidative stress, pro-inflammatory factors and fibrosis. Int Immunopharmacol 2016; 38: 385-394.
7. Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci 2013; 124: 139-152.
8. Kim SW, Ramasamy K, Bouamar H, Lin AP, Jiang D, Aguiar RC. MicroRNAs miR-125a and miR-125b constitutively activate the NF-kappaB pathway by targeting the tumor necrosis factor alpha-induced protein 3(TNFAIP3, A20). Proc Natl Acad Sci USA 2012; 109: 7865-7870.
9. Visekruna A, Joeris T, Seidel D, Kroesen A, Loddenkemper C, Zeitz M , et al. Proteasomemediateddegradation of IkappaBalpha and processing of p105 in Crohn disease and ulcerative colitis. J Clin Investig 2006; 116: 3195-3203.
10. Wu C, Lv C, Chen F, Ma X, Shao Y, Wang Q. The function of miR-199a-5p/Klotho regulating TLR4/NF-kappaB p65/NGAL pathways in rat mesangial cells cultured with high glucose and the mechanism. Mol Cell Endocrinol 2015; 417: 84-93.
11. Pétrilli V, Dostert C, Muruve DA, Tschopp J. The inflammasome: a danger sensing complex triggering innate immunity. Curr Opin Immunol 2007; 19: 615-622.
12. Gao P, Meng XF, Su H, He FF, Chen S, Tang H , et al. Thioredoxin-interacting protein mediates NALP3 inflammasome activation in podocytes during diabetic nephropathy. Biochim Biophys Acta 2014; 1843: 2448-2460.
13. Shahzad K, Bock F, Dong W, Wang H, Kopf S, AI-Dabet MM , et al. Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy. Kidner Int 2015; 87: 74-84.
14. Sakai N, Wada T. Revisiting inflammation in diabetic nephropathy: the role of the Nlrp3 inflammasome in glomerular resident cells. Kidney Int 2015; 87: 12-14.
15. Yang SM, Ka SM, Wu HL, Yeh YC, Kuo CH, Hua KF , et al. Thrombomodulin domain1 ameliorates diabetic nephropathy in mice via anti-NF-B/NLRP3 inflammasome-mediated inflammation, enhancement of NRF2 antioxidant activity and inhibition of apoptosis. Diabetologia 2014; 57: 424-434.
16. Samra YA, Said HS, Elsherbiny NM, Liou GI, EI-Shishtawy MM, Eissa LA. Cepharanthine and Piperine ameliorate diabetic nephropathy in rats: role of NF-B and NLRP3 inflammasome. Life Sci 2016; 157: 187-199.
17. Costa FF. Non-coding RNAs: meet thy masters. Bioessays 2010; 32: 599-608.
18. Ponting CP, Belgard TG. Transcribed dark matter: meaningor myth Hum Mol Genet 2010; 19: R162-R168.
19. Stein LD. Human genome: end of the beginning. Nature 2004; 431: 915-916.
20. Ponting CP, Oliver PL, Reik W. Evolution and functions of long non-coding RNAs. Cell 2009; 136: 629-641.
21. Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H , et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 2012; 22: 1775-1789.
22. Louro R, Smirnova AS, Verjovski-Almeida S. Long intronic noncoding RNA transcription: expression noise or expression choice Genomics 2009; 93: 291-298.
23. Ponjavic J, Ponting CP, Lunter G. Functionality or transcriptional noise Evidence for selection within long noncoding RNAs. Genome Res 2007; 17: 556-565.
24. Liu JY, Yao J, Li XM, Song YC, Wang XQ, Li YJ , et al. Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death Dis 2014; 5: e1506.
25. Wu C, Lv C, Chen F, Ma X, Shao Y, Wang Q. The function of miR-199a-5p/Klotho regulating TLR4/NF-kappaB p65/NGAL pathways in rat mesangial cellscultured with high glucose and the mechanism. Mol Cell Endocrinol 2015; 417: 84-93.
26. Wang M, Yao D, Wang S, Yan Q, Lu W. Long non-coding RNA ENSMUST00000147869 protects mesangial cells from prolife ration and fibrosis induce by diabetic nephropathy. Endocrine 2016; 54: 81-92.
27. Wang M, Wang S, Yao D, Yan Q, Lu W. A novel long non-coding RNA CYP4B1-PS1-001 regulates proliferation and fibrosis in diabetic nephropathy. Mol Cell Endocrinol 2016; 426: 136-145.
28. Zhou L, Xu DY, Sha WG, Shen L, Lu GY, Yin X. Long non-coding MIAT mediates high glucoseinduced renal tubular epithelial injury. Biochem Biophys Res Commun 2015; 468: 726-732.
29. Alvarez ML, Khosroheidari M, Eddy E, Kiefer J. Role of microRNA 1207-5 P and its host gene, the long non-coding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathy. PLos One 2013; 8: e77468.
30. Alvarez ML, Distefano JK. Functional characterization of the plasmacytoma variant translocation 1 gene (PVT1) in diabetic nephropathy. PLoS One 2011; 6: e18671.
31. Millis MP, Bowen D, Kingsley C, Watanabe RM, Wolford JK. Variants in the plasmacytoma variant translocation gene (PVT1) are associated with end-stage renal disease attributed to type 1 diabetes. Diabetes 2007; 56: 3027-3032.
32. Hanson RL, Craig DW, Millis MP, Yeatts KA, Kobes S , et al. Identification of PVT1 as a candidate gene for end-stage renal disease in type2 diabetes using apooling-based genomewide single nucleotide polymorphism association study. Diabetes 2007; 56: 975-983.
33. Alwohhaib M, Alwaheeb S, Alyatama N, Dashti AA, Abdelghani A , et al. Single nucleotide polymorphisms at erythropoietin, superoxide dismutase 1, splicing factor, arginine/serin-rich 15 and plasmacytoma variant translocation genes association with diabetic nephropathy. Saudi J Kidney Dis Transpl 2014; 25: 577-581.
34. Kong J, Sun W, Li C, Wan L, Wang S, Wu Y , et al. Long non-coding RNA LINC01133 inhibits epithelial-mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6. Cancer Lett 2016; S0304-3835: 30410-30414.
35. Pan H, Jiang T, Cheng N, Wang Q, Ren S, Li X , et al. Long non-coding RNA BC087858 induces non-T790M mutation acquired resistance to EGFR-TKls by activating PI3K/AKTand MEK/ERK pathways and EMT in non-small-cell lung cancer. Oncotarget 2016; 7: 49948-49960.
36. Liu B, Sun L, Liu Q, Gong C, Yao Y, Lv X , et al. A cytoplasmic NF-B interacting long noncoding RNA blocks IkB phosphorylation and suppresses breast cancer metastasis. Cancer Cell 2015; 27: 370-381.
37. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F , et al. Long noncodingRNA as modular scaffold of histone modification complexes. Science 2010; 329: 689-693.
38. Martianov I, Ramadass A, Barros AS, Chow N, Akoulitchev A. Repression of thehuman dihydrofolate reductase gene by a non-coding interfering transcript. Nature 2007; 445: 666-670.
39. Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T , et al. NF-kB is activated and promotes cell death in focal cerebral ischemia. Nat Med 1999; 5: 554-559.
40. Donate-Correa J, Martin-Nunez E, Moors-de-Fuentes M, Mora-Fernandez C, Navarro-Gonzalez JF. Inflammatory cytokines in diabetic nephropathy. J Diabetes Res 2015; 2015: 948417.
41. Qguiza A, Recio C, Lazaro I, Mallavia B, Blanco J, Egido J , et al. Peptide-based inhibition of IkB kinase/nuclear factor-kB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type1 diabetes. Diatetologia 2015; 58: 1656-1667.
42. Komati SR, Kasala ER, Bodduluru LN, Mahareddy JR, Uppulapu SK, Gogoi R , et al. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-B pathway. Environ Toxicol Pharmacol 2015; 39: 690-699.
43. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010; 11: 136-140.
44. Sakai N, Wada T. Revisiting inflammation in diabetic nephropathy: the role of the Nlrp3 inflammasome in glomerular residentcells. Kidney Int 2015; 87: 12-14.
45. Fu S, Xu L, Li S, Qiu Y, Liu Y, Wu Z , et al. Baicalin suppresses NLRP3 inflammasome and nuclear factor-kappa B (NF-B) signaling during haemophilus parasuis infection. Vet Res 2016; 47: 80.
46. Huang Z, Zhuang X, Xie C, Hu X, Dong X, Guo Y , et al. Exogenous hydrogen sulfide attenuates high glucose-induced cardiotoxicity by inhibiting NLRP3 inflammasome activation by suppressing TLR4/NF-B pathway in H9c2 cells. Cell Physiol Biochem 2016; 40: 1578-1590.
47. Kong F, Ye B, Lin L, Cai X, Huang W, Huang Z. Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-B signaling in PMA-stimulated THP-1 monocytes. Biomed Pharmacother 2016; 82: 167-172.
48. Zhang X, Fan C, Zhang H, Zhan Q, Liu Y, Xu C , et al. MLKL and FADD are critical for suppressing progressive lymphoproliferative disease and activating the NLRP3 inflammasome. Cell Rep 2016; 16: 3247-3259.
49. Samra YA, Said HS, Elsherbiny NM, Liou GI, El-Shishtawy MM, Eissa LA. Cepharanthine and piperine ameliorate diabetic nephropathy in rats: role of NF-B and NLRP3 inflammasome. Life Sci 2016; 157: 187-199.
50. Luo B, Li B, Wang W, Liu X, Xia Y, Zhang C , et al. NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model. PLoS One 2014; 9: e104771.
51. Qiao Y, Wang P, Qi J, Zhang L, Gao C. TLR-induced NF-B activation regulates NLRP3 expression in murine macrophages. FEBS Lett 2012; 586: 1022-1026.
52. Kaltschmidt C, Kaltschmidt B, Neumann H, Wekerle H, Baeuerle PA. Constitutive NF-kB activity in neurons. Mol Cell Biol 1994; 14: 3981-3992.
53. Baldwin AS Jr. The NF-kB and IkB proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649-683.
54. Kunsch C, Ruben SM, Rosen CA. Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation. Mol Cell Biol 1992; 12: 4412-4421.
55. Kohda A, Yamazaki S, Sumimoto H. The nuclear protein IB Forms a transcriptionally active complex with nuclear factor-B (NF-B) p50 and lcn2 promoter via the N-and C-terminal ankyrin repeat motifs. J Biol Chem 2016; 291: 20739-20752.
56. Ghosh G, Wang VY, Huang DB, Fusco A. NF-B regulation: lessons from structures. Immunol Rev 2012; 246: 36-58.
57. Gordin D, Groop PH. Aspects of hyperglycemia contribution to arterial stiffness and cardiovascular complications in patients with type 1 diabetes. J Diabetes Sci Technol 2016; 10: 1059-1064.
58. Lim SP, Wong NC, Suetani RJ, Ho K, Ng JL, Neilsen PM , et al. Specific-site methylation of tumour suppressor ANKRD11 in breast cancer. Eur J Cancer 2012; 48: 3300-3309.
59. Soncini M, Santoro F, Gutierrez A, Frige G, Romanenghi M , et al. The DNA demethylating agent decitabine activates the TRAIL pathway and induces apoptosis in acute myeloid leukemia. Biochim Biophys Acta 2013; 1832: 114-120.
60. Healy J, Dionne J, Belanger H, Lariviere M, Beaulieu P, Labuda D , et al. Functional impact of sequence variation in the promoter region of TGF1. Int Cancer 2009; 125: 1483-1489.
61. Zhou Q, Huang XR, Yu J, Yu X, Lan HY. Long noncoding RNA Arid2-IR is a novel therapeutic target for renal inflammation. Mol Ther 2015; 23: 1034-1043.
62. Bushehri A, Barez MR, Mansouri SK, Biglarian A, Ohadi M. Genome-wide identification of human-and primate-specific core promoter short tandem repeats. Gene 2016; 587: 83-90.
63. Mathelier A, Fornes O, Arenillas DJ, Chen CY, Denay G, Lee J , et al. JASPAR 2016: a major expansion and update of the open-access database of transcription factor binding profiles. Nucleic Acids Res 2016; 44: D110-D115.
64. Thomas-Chollier M, Hufton A, Heinig M, O'Keeffe S, Masri NE, Roider HG , et al. Transcription factor binding predictions using TRAP for the analysis of ChIP-seq data and regulatory SNPs. Nat Protoc 2011; 6: 1860-1869.
65. Loots GG, Ovcharenko I. rVISTA 2.0: evolutionary analysis of transcription factor binding sites. Nucleic Acids Res 2004; 32: W217-W221.
66. Qiao MX, Li C, Zhang AQ, Hou LL, Yang J, Hu HG. Regulation of DEK expression by AP-2 and methylation level of DEK promoter in hepatocellular carcinoma. Oncol Rep 2016; 36: 2382-2390.
67. Fang Y, Yan J, Li C, Zhou X, Yao L, Pang T, Yan M , et al. The Nogo/Nogo receptor (NgR) signal is involved in neuroinflammation through the regulation of microglial inflammatory activation. J Biol Chem 2015; 290: 28901-28914.
68. He Q, Zhang C, Wang L, Zhang P, Ma D, Lv J, Liu F. Inflammatory signaling regulates hematopoietic stem and progenitor cell emergence in vertebrates. Blood 2015; 125: 1098-1106.
69. He L, Sun F, Wang Y, Zhu J, Fang J, Zhang S , et al. HMGB1 exacerbates bronchiolitis obliterans syndrome via RAGE/NF-B/HPSE signaling to enhance latent TGF-release from ECM. Am J Transl Res 2016; 8: 1971-1984.
70. Chian CF, Chiang CH, Chuang CH, Liu SL. Inhibitor of nuclear factor-B, SN50, attenuates lipopolysaccharide-induced lung injury in an isolated and perfused rat lung model. Transl Res 2014; 163: 211-220.
71. Letoha T, Somlai C, Takacs T, Szabolcs A, Jarmay K, Rakonczay Z Jr , et al. A nuclear import inhibitory peptide ameliorates the severity of cholecystokinin-induced acute pancreatitis. World J Gastroenterol 2005; 11: 990-999.
72. Chian CF, Chiang CH, Chuang CH, Liu SL, Tsai CL. SN50, a cell-permeable inhibitor of nuclear factor-B, attenuates ventilator-induced lung injury in an isolated and perfused Rat Lung Model. Shock 2016; 46: 194-201.